Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.2 |
mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |